Pause at a missing prescription or a misleading claim

Do not treat a missing prescription as convenience

Under the federal rule recorded September 26, 2026, dispensing a prescription drug without the required prescription violates the law.

If nobody has decided whether to prescribe, wait before paying. Ask who will assess you and make that decision.

Ask what “approved” refers to

As of September 26, 2026, FDA said claiming its approval for a medicine prepared to order is false or misleading.

A National Drug Code number identifies a listing; it does not show that FDA approved the product.

Ask to see the record being relied on. A badge or an ingredient code is a prompt for a question, not an answer about the proposed product.

A research label does not settle intended use

In its 2026 warning letters, FDA challenged sellers who labelled products for research while promoting use in people and providing supplies for injections.

“Research-only” means labelled for research, rather than for treating a person. Ask why a product with that label is being offered for your care.

Those letters set out FDA’s accusations about particular firms; they are not court judgments.

Ask who made the product and what prescribing and pharmacy records apply. If the answer remains a slogan, keep the gap marked.